Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Salvacyl, 11.25 mg powder and solvent for prolonged-release suspension for injection

Active Ingredient:
triptorelin embonate
Company:  
Ipsen Ltd See contact details
ATC code: 
L02AE04
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Product Information HCP Med Info
{arrow_left}
{arrow_right}
Product Information – Amended handling instructions for Salvacyl® (triptorelin) with safety needle

Amended handling instructions for Salvacyl including the addition of a safety needle have been approved and can be found in the Summary of Product Characteristics (SPC) and the package leaflet (PIL). Existing stocks in the supply chain may take some months to run down. To check that these instructions apply to your Salvacyl pack, ensure that the contents listed on the box include one safety injection needle. Packs including these needles contain the revised handling process.

This information is not applicable to Salvacyl without the safety injection needle. For the SPC/PIL for Salvacyl without the safety needle please contact Ipsen Medical Information on 01753 627777.

Ipsen Ltd
Company image
Address
5th Floor, The Point, 37 North Wharf Road, London, W2 1AF, UK
Telephone
+44 (0)1753 627 777
Medical Information Direct Line
+44 (0)1753 627 777
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)1753 627 627